[Clinico-epidemiological implications of autochthonous infection caused by Entamoeba histolytica].
J
J
Rodríguez Hernández
A
A
Canut Blasco
M F
MF
Brezmes Valdivieso
I
I
de Fuentes
D000328:Adult; D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004404:Dysentery, Amebic / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D004749:Entamoebiasis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D011537:Pruritus / Q000209:etiology; D013030:Spain / Q000453:epidemiology; D013997:Time Factors
D000981:Antiprotozoal Agents; D008795:Metronidazole
Implicaciones clínico-epidemiológicas de la infección autóctona por Entamoeba histolytica.